Symbiotec Pharmalab Limited IPO: Launch Date, Share Price, Size & Review
Symbiotec Pharmalab Ltd. was incorporated in 2002 and it is a pharmaceutical and biotechnology company engaged in the development and manufacturing of active pharmaceutical ingredients, nutritional ingredients, and specialty products. It supports pharmaceutical, nutraceutical, and wellness industries by delivering high-quality, innovative ingredients aligned with global standards. The company caters to domestic and international markets across regulated and emerging regions. As of June 30, 2025, they had two operational industrial-scale API manufacturing facilities with a maximum chemical synthesis capacity of 584.67 metric tonnes (“MT”) and fermentation capacity of 300 kilolitres.